Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Yoshioka

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
World Journal of Hepatology|December 9, 2015
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma developmentSatoshi Shakado, Shotaro Sakisaka, Kazuaki Chayama, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 16, 2009
Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis CTakashi Honda, Yoshiaki Katano, Junichi Shimizu, et al.
Kidney International|December 2, 2021
Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney diseaseKentaro Yoshioka, Yosuke Hirakawa, Makoto Kurano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2014
Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus-related liver cirrhosis: A multicenter retrospective study in JapanSatoshi Shakado, Shotaro Sakisaka, Takeshi Okanoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 2, 2016
HLA-DQ gene polymorphisms are associated with hepatocellular carcinoma and hepatitis B surface antigen in chronic hepatitis B virus infectionYuka Ochi, Senju Hashimoto, Naoto Kawabe, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 4, 2015
The NAFLD Index: A Simple and Accurate Screening Tool for the Prediction of Non-Alcoholic Fatty Liver DiseaseNaohiro Ichino, Keisuke Osakabe, Keiko Sugimoto, et al.
Springerplus|February 26, 2015
PNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patientsKazunori Nakaoka, Senju Hashimoto, Naoto Kawabe, et al.
Journal of Gastroenterology|August 9, 2011
Reduction of liver stiffness by antiviral therapy in chronic hepatitis BKeisuke Osakabe, Naohiro Ichino, Toru Nishikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 30, 2013
Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28BKazuhiko Hayashi, Yoshiaki Katano, Hiroko Masuda, et al.
World Journal of Gastroenterology|February 28, 2014
Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis CToru Nishikawa, Senju Hashimoto, Naoto Kawabe, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
World Journal of Hepatology|December 9, 2015
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma developmentSatoshi Shakado, Shotaro Sakisaka, Kazuaki Chayama, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 16, 2009
Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis CTakashi Honda, Yoshiaki Katano, Junichi Shimizu, et al.
Kidney International|December 2, 2021
Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney diseaseKentaro Yoshioka, Yosuke Hirakawa, Makoto Kurano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 10, 2014
Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus-related liver cirrhosis: A multicenter retrospective study in JapanSatoshi Shakado, Shotaro Sakisaka, Takeshi Okanoue, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 2, 2016
HLA-DQ gene polymorphisms are associated with hepatocellular carcinoma and hepatitis B surface antigen in chronic hepatitis B virus infectionYuka Ochi, Senju Hashimoto, Naoto Kawabe, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|November 4, 2015
The NAFLD Index: A Simple and Accurate Screening Tool for the Prediction of Non-Alcoholic Fatty Liver DiseaseNaohiro Ichino, Keisuke Osakabe, Keiko Sugimoto, et al.
Springerplus|February 26, 2015
PNPLA3 I148M associations with liver carcinogenesis in Japanese chronic hepatitis C patientsKazunori Nakaoka, Senju Hashimoto, Naoto Kawabe, et al.
Journal of Gastroenterology|August 9, 2011
Reduction of liver stiffness by antiviral therapy in chronic hepatitis BKeisuke Osakabe, Naohiro Ichino, Toru Nishikawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 30, 2013
Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28BKazuhiko Hayashi, Yoshiaki Katano, Hiroko Masuda, et al.
World Journal of Gastroenterology|February 28, 2014
Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis CToru Nishikawa, Senju Hashimoto, Naoto Kawabe, et al.
Pageof 9